论文部分内容阅读
目的:通过与单纯神经内科常规治疗的比较,观察开塞通胶囊联合卒中单元治疗急性脑梗死的临床疗效。方法:将采用开塞通胶囊联合卒中单元治疗(治疗组)与单纯神经内科常规治疗(对照组)病人的神经功能缺损程度,日常生活活动能力(ADL)Barthel指数,临床疗效进行比较。结果:治疗组神经功能缺损程度,日常生活活动能力(ADL)Barthel指数,临床疗效均显著优于对照组(P<0.01)。结论:开塞通胶囊联合卒中单元治疗急性脑梗死能显著提高患者早期日常生活能力,减少神经功能缺损,提高临床疗效。
OBJECTIVE: To observe the curative effect of Kaiseron capsule combined with stroke unit in the treatment of acute cerebral infarction by comparing with conventional neurology. Methods: The neurological deficit, Barthel index of ADL and clinical efficacy were compared between the patients treated with Kaiseron capsule and stroke unit (treatment group) and those treated routinely with neurological department (control group). Results: The degree of neurological deficit, Barthel index of daily living activity (ADL) and clinical efficacy in the treatment group were significantly better than those in the control group (P <0.01). Conclusion: Kaixintong capsule combined with stroke unit can significantly improve the ability of patients with early daily life, reduce neurological deficits and improve clinical efficacy in patients with acute cerebral infarction.